Ingredient

Boswellia

Products with Boswellia on sale in the United Kingdom.

Find products
Share

Email article

Boswellia is the gum resin of Boswellia serrata, a tree native to Northern Africa, India and the Middle East. It is also called Indian frankincense. Supplements contain extracts of the resin, some standardized to boswellic acids, its triterpene acids. Some extracts also keep the resin's volatile compounds.

Terms and sources
native to Northern Africa, India and the Middle East
NCCIH, Boswellia: Usefulness and Safety.
Indian frankincense
Riva et al., Phytomedicine, 2016, a trial report below.
boswellic acids
Hammer et al. name AKBA, KBBA, β-boswellic acid and 3-acetyl-β-boswellic acid as the main ones. Hammer et al., Nutrients, 2026, a trial report below.
volatile compounds
Such as α-thujene. Joseph et al., Biological and Pharmaceutical Bulletin, 2024, a trial report below.

Boswellia in the body

Boswellia is not a nutrient, and the body has no daily requirement for it. Trials in adults without a diagnosis measure pain tests and boswellic acids in blood.

In one trial, blood boswellic acids were higher when an extract was taken with a high-fat meal than fasting. Two α-boswellic acids were detectable only with the meal. Hammer et al. write that blood AKBA after oral intake stays far below the level that blocks 5-lipoxygenase in lab tests.

Terms and sources
In one trial
Sterk et al., Planta Medica, 2004, below.
5-lipoxygenase
An enzyme of inflammation signaling that AKBA blocks in lab tests. Hammer et al., Nutrients, 2026, a trial report below.

Safety: what NCCIH says

NCCIH, on safety: "Boswellia is likely to be safe when taken orally." NCCIH adds: "Boswellia serrata extract in doses up to 1,000 mg daily has been safely used in several clinical trials lasting up to 6 months." NCCIH adds: "It has also been used with apparent safety at a dose of 2,400 mg for up to 1 month." NCCIH adds: "Boswellia (frankincense) may be safe to use topically or for aromatherapy."

Terms and sources
on safety
Quoted in full from the NCCIH page's safety section; the last sentence is from its Keep in Mind section. NCCIH, Boswellia: Usefulness and Safety.

NCCIH adds: "If you have asthma, follow your health care provider’s recommendations on how to manage your condition. For your safety:" NCCIH adds: "Do not substitute other approaches for treatments recommended or prescribed by your health care provider." NCCIH adds: "Consult your health care provider about adding any complementary health products or practices to your asthma management program. If you take medicine for asthma, talk with your provider before starting to take a dietary supplement. Some dietary supplements and medicines can interact in harmful ways."

NCCIH adds: "No complementary approach has been shown to cure cancer or cause it to go into remission. Some products or practices that have been advocated for cancer treatment may interfere with conventional cancer treatments or have other risks. If you’ve been diagnosed with cancer, you should consult your health care providers before using any complementary health approach."

NCCIH adds: "It is likely safe to use boswellia in amounts commonly found in foods during pregnancy or while breastfeeding. Little is known about whether it’s safe to use boswellia orally in medicinal amounts or to use frankincense during pregnancy or while breastfeeding."

NCCIH, in Keep in Mind: "If you take any type of medicine, talk with your health care provider before using any herbal product; some herbs and medicines interact in harmful ways."

Where boswellia comes from

Boswellia serrata is a tree of the Burseraceae family. Its dried resin has been used in Ayurvedic medicine for centuries. The resin holds volatile compounds, such as terpenes, and non-volatile boswellic acids. Hammer et al. write that four main boswellic acids make up about 14% of the fat-soluble extract fraction.

Terms and sources
Burseraceae
Italian Ministry of Health, list of plants for food supplements, 2018.
for centuries
Hammer et al., Nutrients, 2026, a trial report below.
volatile compounds
Joseph et al., Biological and Pharmaceutical Bulletin, 2024.
about 14%
Hammer et al., Nutrients, 2026, a trial report below.

Daily amounts and the upper limit

United States

There is no US recommended daily amount for boswellia. The National Academies have not set an upper limit for boswellia.

In the NIH label database, 2,180 US labels list Boswellia serrata or its extracts. 92% of them list other ingredients too. Another 44 labels name only another Boswellia species, and 83 say frankincense without naming a species.

Terms and sources
2,180 US labels
NIH Dietary Supplement Label Database, including products no longer sold. Labels with an ingredient or form named boswellia, boswellic acid, Indian frankincense, salai, shallaki, olibanum or a branded boswellia extract. We counted these.
92%
1,997 of 2,180. Labels where every ingredient is boswellia or its boswellic acids are counted as boswellia only. Calorie and carbohydrate rows are ignored.
another Boswellia species
Such as Boswellia carterii or Boswellia sacra. These labels are not in the 2,180. We counted these.

Of the 2,180 labels, 1,157 also list turmeric or curcumin, and 832 list glucosamine.

Terms and sources
1,157
We counted these. 692 also list MSM, and 581 list chondroitin.

In 129 extract labels whose only ingredient is boswellia, the middle half list 250–500 mg per serving. Labels that do not call it an extract list more: the middle half of 45 list 300–1,400 mg.

Terms and sources
129 extract labels
The median is 400 mg. Amounts in mg or g, converted to mg. A serving is not always a full day's amount.
per serving
Left out: 4 labels in teaspoons, 4 that list boswellia twice, and 1 with no unit. We counted these.
45
Ingredient names without the word extract. The median is 800 mg.

58 labels give both the boswellia and the boswellic acid amount in mg. Of these, 22 come to 65% and 16 to 60%. 364 labels name AKBA.

Terms and sources
22 come to 65%
By our calculation. 8 come to 40%, 4 to 70% and 3 to 50%.
364 labels
As AKBA or acetyl-11-keto-β-boswellic acid, in an ingredient name, a form or a separate row. We counted these.

Branded extracts on these labels include 5-Loxin on 163, Boswellin on 149, ApresFlex on 129 and Aflapin on 15.

Terms and sources
5-Loxin on 163
Names as printed on the label. Casperome appears on 7. We counted these.

Of 183 labels whose only ingredient is boswellia, 150 carry a precaution to consult a doctor or health professional.

Terms and sources
150 carry a precaution
A precaution statement on the label with the words consult, physician or ask a doctor. We counted these.

Forms of boswellia and how they differ

Supplements sell boswellia as gum resin or as extracts of it. Some extracts are enriched in AKBA; one in the trials below held at least 30% AKBA. Two trials below compared newer forms with a plain extract: one with lecithin, one in a hydrogel.

Terms and sources
at least 30% AKBA
BoswellinSuper, by the maker's specification as given in the trial report. Hammer et al., Nutrients, 2026, a trial report below.
newer forms
Riva et al., 2016, and Joseph et al., 2024, below.
Boswellia resin, extracts and formulations in the studies below
FormWhat it isStudies below
Plain extractDry extract of the gum resin, no new formulationSterk 2004 (786 mg of BSE-018); the comparison form in Riva 2016 and Joseph 2024
Standardized extractExtract with a stated share of boswellic acids; BoswellinSuper: 75% total boswellic acids and at least 30% AKBA, per the makerHammer 2026 (600 mg a day)
Lecithin formulationStandardized extract formulated with lecithinRiva 2016: five of six boswellic acids in blood were higher than with the plain extract
Hydrogel formulationBFQ-20: extract in a hydrogel made with fenugreek mucilageJoseph 2024: boswellic acids in blood were higher than with the unformulated extract
Branded capsulesShallaki, Boswellia serrata, form not statedPrabhavathi 2014 (250 mg once)

What it is: the trial reports named in the third column.

Published studies of boswellia

Most boswellia trials studied people with a diagnosis, often of the joints. Those trials are not listed here, nor are studies of boswellia mixed with other ingredients. Studies of boswellia on the skin, in the mouth or inhaled are not listed either.

We list trials with up to 1,000 mg of Boswellia serrata extract a day.

Terms and sources
up to 1,000 mg
NCCIH: "Boswellia serrata extract in doses up to 1,000 mg daily has been safely used in several clinical trials lasting up to 6 months. It has also been used with apparent safety at a dose of 2,400 mg for up to 1 month." NCCIH, Boswellia: Usefulness and Safety.

5 studies in adults without a diagnosis. Against a dummy product, 1 found no difference and 1 had mixed results. 2 compared forms, and 1 compared taking an extract with and without a meal.

12 to 16 people each, where given; one abstract gives no number. Not listed: studies in people with a diagnosis, after surgery or taking medicines. Nor are studies that chose people by a memory or knee pain score. Also not listed: boswellia mixed with other ingredients, or used on the skin, in the mouth or inhaled. Nor are studies that included or may have included people under 18. Also not listed: reviews that include such studies, and studies without an abstract. Nor are trials without a stated random order or comparison group. All 5 trials that qualify are listed.

Our one-line summary comes first. The original is on PubMed.

Show the 5 studies
  • 16 healthy volunteers took single 400 mg doses of two boswellia extracts; blood boswellic acids were higher with one.

    Trial · 16 people · Single doses · industry author

    Joseph et al., Biological and Pharmaceutical Bulletin, 2024

    Terms and sources
    two boswellia extracts
    BFQ-20, a full-spectrum Boswellia serrata extract in a hydrogel made with fenugreek mucilage, and an unformulated boswellia extract. The abstract also names a placebo without saying how it was used.
    higher with one
    Boswellic acids, area under the blood curve: 9,484 with BFQ-20 and 2,366 ng·h/mL unformulated (p < 0.001). α-Thujene, a volatile compound, was not detectable after the unformulated extract.
    industry author
    All four authors work at the research center of Akay Natural Ingredients. We read only the abstract, so we could not check who paid.

    Study · Free full text · about 2 min to read

    Free full text on J-STAGE under a CC BY-NC license. We could not read the full text. Our estimate at about 200 words a minute, from the PubMed abstract.

    Study summary

    16 healthy volunteers took single 400 mg doses of two forms of a Boswellia serrata extract, in turn. One was BFQ-20, held in a hydrogel made with fenugreek mucilage. The other was an unformulated extract. Boswellic acids in blood, as area under the curve, were 9,484 with BFQ-20 and 2,366 ng·h/mL unformulated. α-Thujene, a volatile compound, was detectable only after BFQ-20. Funding: all authors work at Akay Natural Ingredients. We read only the abstract.

  • 12 healthy adults took a boswellia extract and dummy capsules for 28 days each; pain tests did not differ.

    Trial · 12 people · 28 days each

    Hammer et al., Nutrients, 2026

    Terms and sources
    12 healthy adults
    Aged 18 or older, without chronic pain, regular painkillers or interacting medicines. Each took both products in random order, with 4 weeks between.
    a boswellia extract
    BoswellinSuper, 300 mg twice a day (600 mg a day), from Sabinsa Europe GmbH. By the maker's specification: 75% total boswellic acids, at least 50% β-boswellic acid and 30% AKBA.
    dummy capsules
    Capsules of maltodextrin, identical in look.
    pain tests did not differ
    Pain after a capsaicin patch on the forearm: 43 with boswellia and 47 with dummy capsules, of 100 (p = 0.539). Heat, pinprick, touch and cold tests and mood, sleep and well-being questionnaires did not differ either.
    28 days each
    No unwanted events were reported with either product. The Results text gives the heat pain threshold with boswellia as 34.77 °C; the table gives 36.84 °C.

    Study · Free full text · about 21 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    A pilot trial in Graz gave 12 healthy adults BoswellinSuper, 300 mg twice a day, for 28 days. Each also took dummy capsules for 28 days, in random order. After each period, a capsaicin patch caused pain on the forearm. Pain was 43 with boswellia and 47 with dummy capsules on a 0–100 scale. Heat, pinprick, touch and cold tests and mood, sleep and well-being questionnaires did not differ. No unwanted events were reported. Funding: the City of Graz cultural office paid; the authors declare no conflicts.

  • 12 healthy volunteers took lecithin-formulated and plain boswellia extracts; five of six boswellic acids in blood were higher with lecithin.

    Trial · 12 people · Single doses · industry author

    Riva et al., Phytomedicine, 2016

    Terms and sources
    lecithin-formulated and plain boswellia extracts
    A standardized Boswellia serrata extract and its lecithin formulation, called CSP in the report. Two 250 mg capsules of each, as single doses in random order, open label.
    five of six boswellic acids
    KBA did not differ. The other five were higher and were absorbed faster with the lecithin form, both by weight and by molar amount.
    industry author
    Four of nine authors work at Indena S.p.A. We could not read the full text, so we could not check who paid.

    Study · Free full text · about 2 min to read

    Free full text on the publisher's site under a CC BY-NC-ND license, as Europe PMC lists it. We could not read the full text. Our estimate at about 200 words a minute, from the PubMed abstract.

    Study summary

    An open-label study gave 12 healthy volunteers single doses of two Boswellia serrata forms, in random order. One was a standardized extract, the other its lecithin formulation. Each dose was two 250 mg capsules. Six boswellic acids were measured in blood. KBA did not differ. The other five were higher and were absorbed faster with the lecithin form, by weight and by molar amount. The abstract gives no numbers. Funding: four authors work at Indena; we read only the abstract.

  • 12 healthy men took one dose of boswellia and of dummy capsules; pain-pressure tests differed only at some time points.

    Trial · 12 people · Single doses

    Prabhavathi et al., Indian Journal of Pharmacology, 2014

    Terms and sources
    12 healthy men
    Aged 18–45, average 36.6. People using painkillers or other medicines that change pain were left out.
    boswellia
    Shallaki, a Boswellia serrata product: two 125 mg capsules once. The report does not name the maker or say whether it is an extract.
    dummy capsules
    Identical placebo capsules, taken 2 weeks before or after boswellia, in random order.
    differed only at some time points
    An analysis across all time points found no difference between products. At 3 hours, pain threshold force rose 9.7% with boswellia and 2.9% with dummy capsules (p = 0.05). Time to pain threshold also rose more with boswellia at 3 hours: 9.7% vs 2.8% (p = 0.04). Pain tolerance rose more with boswellia at 1, 2 and 3 hours (p ≤ 0.01).
    pain-pressure tests
    A device pressed on a finger; no participant reported unwanted events, and blood and urine tests stayed normal.

    Study · Free full text · about 15 min to read

    Our estimate at about 200 words a minute, from the PMC full text.

    Study summary

    A trial in Hyderabad, India, gave 12 healthy men aged 18–45 one dose of Shallaki, a Boswellia serrata product. Each took two 125 mg capsules once and identical dummy capsules once, in random order, 2 weeks apart. A device pressing on a finger measured pain threshold and tolerance at 1, 2 and 3 hours. An analysis across all time points found no difference. Single time points differed at some hours. No unwanted events were reported. Funding: the report lists no funding and no conflicts of interest.

  • Healthy men took a boswellia extract fasting and with a high-fat meal; blood boswellic acids were higher with the meal.

    Trial · The abstract does not give the number of participants. · Single doses · funding not stated

    Sterk et al., Planta Medica, 2004

    Terms and sources
    Healthy men
    The abstract does not give the number of men.
    a boswellia extract
    Three capsules of BSE-018, equal to 786 mg of a dry extract of Boswellia serrata gum resin. Single doses in random order, open label.
    higher with the meal
    Blood levels over time and peak levels of β-boswellic acid, KBA and AKBA were higher with the meal. Two α-boswellic acids were detectable only with the meal. The abstract gives no numbers. The abstract does not say whether the differences were statistically significant.
    funding not stated
    We read only the abstract, which does not say who paid. The authors are at the University of Ulm.

    Study · Abstract only · about 2 min to read

    Abstract only. Our estimate at about 200 words a minute, from the PubMed abstract.

    Study summary

    An open study at the University of Ulm gave healthy men single doses of BSE-018. This equals 786 mg of a dry Boswellia serrata gum resin extract. They took it once fasting and once with a high-fat meal, in random order. Blood was sampled for up to 60 hours. Blood levels and peak levels of three boswellic acids were higher with the meal. Two α-boswellic acids were detectable only with the meal. Funding: not stated in the abstract.

Sources

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.

Products with Boswellia on sale in the United Kingdom

View products with filters

Lowest price per day first. Status shown for the United Kingdom.

No products match this list.

Not sure what to choose, or couldn’t find what you were looking for? Ask our expert

Information, not a prescription. Do not start, stop or combine supplements or medicines on your own. If you have a health condition, are pregnant or breastfeeding, take medicines, or are under 18, talk to a doctor or pharmacist first.